BioSpace News Archive

TMR’s report on the global ambulance services market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market for the forecast period of 2019 to 2027.

In terms of revenue, the global personal mobility devices market is projected to expand at a CAGR of ~ 7% during the forecast period, due to numerous factors, about which, TMR offers comprehensive insights and forecasts in the global personal mobility devices market report.

Rising need to decongest healthcare spaces to enhance patient comfort enhancing popularity across key geographies

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces the participation of members of the company’s senior management team in four investor and R&D conferences being held virtually during April 2021.

BioInvent International AB announced that the company’s total number of shares as per March 31, 2021 amounts to 58,471,096 shares, corresponding to an equal number of votes.

Pharnext SA, an advanced late-stage clinical biopharmaceutical company pioneering new approaches to developing innovative drug combinations based on big genomics data and artificial intelligence using its PLEOTHERAPY platform, announces that the first subject has been enrolled in its pivotal Phase III clinical study of PXT3003 in the U.S. at the Austin Neuromuscular Center.

Opthea Limited announces that it has received an initial Pediatric Study Plan waiver from the US Food and Drug Administration for OPT-302, the Company’s lead product candidate currently in Phase 3 clinical development for the treatment of neovascular age-related macular degeneration.

Company is Ramping up Production of the Product in Anticipation of a Potential Expansion of the Supply to the IMOH and Possible Demand from Additional International Markets

Funds managed by SK Capital Partners LP, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, completed the previously announced acquisition of the Blow-Fill-Seal (“BFS”) Sterile Contract Development and Manufacturing business from Catalent Pharma Solutions, LLC.

Athersys, Inc. announced that its partner HEALIOS K.K. has completed enrollment in the ONE-BRIDGE study in Japan evaluating MultiStem® in patients with acute respiratory distress syndrome caused by pneumonia.